26 May 2013
Keywords: roche, xeloda, sees, strong, ph, iii, data
Article | 12 June 2006
Swiss drug major Roche says that results from the largest-ever Phase III study in advanced esophagogastric cancer, were presented at ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 2006
8 May 2006
24 May 2013
© 2013 thepharmaletter.com